-
China approves new COVID-19 vaccine for clinical trials
2021-04-12
The new recombinant COVID-19 vaccine, developed by the National Vaccine & Serum Institute, a R&D center of Sinopharm's bioscience subsidiary the China National Biotec Group (CNBG), got approval from the National Medical Products Administration on April 9, the CNBG said on its official Weibo account on Saturday.
-
NMPA holds symposium on process and prospects of ICH in China
2021-04-10
The National Medical Products Administration (NMPA) held a symposium on the process and prospects of the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) in Beijing on April 7 to review the progress of China's participation in the ICH and discuss follow-up work plans.
-
Chinese mainland reports 8 new locally transmitted COVID-19 cases
2021-04-09
The Chinese mainland on Thursday reported eight new locally transmitted COVID-19 cases in Yunnan province, the National Health Commission said onn April 9.
-
Over 149m COVID-19 vaccine doses administered across China
2021-04-09
More than 149 million doses of COVID-19 vaccines had been administered across China as of Wednesday, the National Health Commission said on April 9.
-
Chinese mainland reports 11 new locally transmitted COVID-19 cases
2021-04-08
The Chinese mainland on Wednesday reported 11 new locally transmitted COVID-19 cases in Yunnan province, the National Health Commission said on April 8.
-
Over 145m COVID-19 vaccine doses administered across China
2021-04-08
More than 145.39 million doses of COVID-19 vaccines had been administered across China as of Tuesday, the National Health Commission said on April 7.
